Effect of halofuginone on the development of tight skin (TSK) syndrome

Autoimmunity

Volumn 35, Issue 4, 2002, Pages 277-282

  Gaha, Tracy M c ^a   Kodera, Takao ^a   Phelps, Robert ^a   Spiera, Harry ^a   Pines, Mark ^b   Bona, Constantin ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b VOLCANI CENTER   (Israel)

Author keywords

Collagen; Fibrosis; Halofuginone; Scleroderma; Tight skin mouse

Indexed keywords

ANTIGEN; AUTOANTIBODY; COLLAGEN TYPE 1; DNA TOPOISOMERASE; FIBRILLIN; HALOFUGINONE; HYDROXYPROLINE; COLLAGEN; PIPERIDINE DERIVATIVE; PROTEIN SYNTHESIS INHIBITOR; QUINAZOLINE DERIVATIVE; QUINAZOLINONE DERIVATIVE;

ADULTHOOD; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY BLOOD LEVEL; ARTICLE; CLINICAL FEATURE; COLLAGEN SYNTHESIS; CONNECTIVE TISSUE; CONTROLLED STUDY; CORRELATION ANALYSIS; DRUG EFFECT; FIBROBLAST; GENETIC DISORDER; GENETIC TRANSCRIPTION; HYPERPLASIA; IN VIVO STUDY; LUNG EMPHYSEMA; MORBIDITY; MORTALITY; MOUSE; NEWBORN; NONHUMAN; SCLERODERMA; TIGHT SKIN SYNDROME; ANIMAL; C57BL MOUSE; DISEASE MODEL; FIBROSIS; HUMAN; METABOLISM; MOUSE MUTANT; SKIN DISEASE; SYSTEMIC SCLEROSIS;

ANIMAL; ANIMALS, NEWBORN; COLLAGEN; DISEASE MODELS, ANIMAL; FIBROSIS; HUMAN; MICE; MICE, INBRED C57BL; MICE, MUTANT STRAINS; PROTEIN SYNTHESIS INHIBITORS; QUINAZOLINES; SCLERODERMA, SYSTEMIC; SKIN DISEASES; SUPPORT, U.S. GOV'T, P.H.S.; ANIMALS; HUMANS; PIPERIDINES; QUINAZOLINONES;

EID: 0035995041     PISSN: 08916934     EISSN: None     Source Type: Journal    
DOI: 10.1080/0891693021000001235     Document Type: Article

References (33)

1. Regulation of connective tissue synthesis in systemic sclerosis
2. Autoantibodies in scleroderma and tight skin mice
3. Anti-fibrillin autoantibodies in scleroderma and MCTD diseases
4. A new 350-kD glycoprotein is a new component of extracellular microfibrils
5. Recombinant human relaxin in the treatment of scleroderma. A randomized, double blind, placebo-controlled trial
6. A defect in the intramolecular and intermolecular cross-linking of collagen caused by penicillamine. I. Metabolic and functional abnormalities in soft tissues
7. Studies on beta-aminopropionitrile in patients with scleroderma
8. Iloprost suppresses connective tissue growth factor production in fibroblasts and in the skin of scleroderma patients
9. A new promising treatment in systemic sclerosis: 5-Fluorouracil
10. Halofuginone: An inhibitor of collagen type I synthesis
11. Inhibition of collagen synthesis and changes in skin morphology in murine graft versus host diseases: Effect of halofuginone
12. Topical treatment of cutaneous graft versus host disease (cGVHD) with halofuginone: A novel inhibitor of collagen type I synthesis
13. Reduction of pulmonary fibrosis in vivo by halofuginone
14. Halofuginone, a specific inhibitor of collagen type I synthesis, prevents dimethylnitrosamine-induced liver cirrhosis
15. Tight skin, a new mutation in the mouse causing excessive growth of connective tissue and skeleton
16. Anti-topoisomerase I monoclonal antibodies from scleroderma patients and tight skin mouse interact with the same epitopes
17. Immunochemical and molecular characterization of anti-RNA polymerase I autoantibodies produced by tight-skin mice
18. Self-reactive repertoire of tight skin mouse: Immunochemical and molecular characterization of anti-cellular antibodies
19. Spontaneous occurrence of anti-fibrillin-1 autoantibodies in tight skin mice
20. Halofuginone, an inhibitor of type-I collagen synthesis and skin sclerosis, blocks TGF-β mediated Smad3 activation in fibroblasts
21. A tandem duplication within the fibrillin-1 gene is associated with tight skin mutation
22. Genetic defects in tight skin mice developing a scleroderma-like syndrome
23. Halofuginone to prevent and treat thioacetamide-induced liver fibrosis
24. Correlation between the concentration of serum anti-topoisomerase 1 autoantibodies and histological and biochemical alterations in the skin of tight skin mice
25. Topically applied halofuginone, an inhibitor of collagen type-I transcription, reduces peritnedinous fibrous adhesions following surgery
26. Hereditary emphysema in tight skin mice
27. Halofuginone, an inhibitor of collagen type I synthesis prevents postoperative adhesion formation in the rat uterine horn model
28. Induction of skin fibrosis in mice expressing a mutated Fibrillin-1 gene
29. Lack of skin fibrosis in tight skin (TSK) mice with targeted mutation in the interleukin-4Rα and transforming growth factor-β genes
30. Disrupting the IL-4 gene rescues mice homozygous for the tight-skin mutation from embryonic death and diminishes TGF-β production by fibroblasts
31. Scleroderma autoantigens are uniquely fragmented by metal-catalyzed oxidation reactions
32. New insights into the assembly of extracellular microfibrils from the analysis of the fibrillin 1 mutation in the tight skin mouse
33. Abnormalities in fibrillin 1-containing microfibrils in dermal fibroblast cultures from patients with systemic sclerosis (scleroderma)